Prosecution Insights
Last updated: April 19, 2026

Halozyme Inc.

8 pending office actions

Portfolio Summary

8
Total Pending OAs
1
Final Rejections
7
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19358181 METHODS OF TREATING TUMORS BENAVIDES, JENNIFER ANN 1675 Non-Final OA Oct 14, 2025
19071092 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF NOAKES, SUZANNE MARIE 1656 Non-Final OA Mar 05, 2025
19071005 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF HOLLAND, PAUL J 1656 Non-Final OA Mar 05, 2025
19071264 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF STEADMAN, DAVID J 1656 Non-Final OA Mar 05, 2025
19071055 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF HOLLAND, PAUL J 1656 Non-Final OA Mar 05, 2025
18846136 BUTTON ACTUATED AUTOINJECTOR DANIEL, ANTARIUS S 3783 Non-Final OA Sep 11, 2024
18332893 DOSING REGIMEN PAGUIO FRISING, MICHELLE F 1651 Non-Final OA Jun 12, 2023
18059135 COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME BARRON, SEAN C 1653 Final Rejection Nov 28, 2022

Managing Halozyme Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month